title: 13-valent pneumococcal conjugate vaccine: a review of its use in infants, children, and adolescents.
abstract: The 13-valent pneumococcal conjugate vaccine (Prevenar 13(®); Prevnar 13(®)) [PCV13] includes 13 serotype-specific polysaccharides of Streptococcus pneumoniae conjugated individually to non-toxic diphtheria CRM197 protein, thus providing wider coverage of pneumococcal serotypes than its 7-valent predecessor (PCV7). For pediatric populations, PCV13 was initially approved for use in infants and children up to 5 years of age, but recently received approval for expanded use (ages 6 weeks to 17 years) in the EU and the USA. This change in labeling was made primarily on the basis of results of Study 3011, which demonstrated the serotype-specific immunogenicity of a single dose of PCV13 in children ≥5 to <10 years of age who had previously received PCV7. Study 3011 also demonstrated functional immune responses after a single dose of PCV13 in a cohort ≥10 to <18 years of age who had not previously received PCV7. Importantly, prior to Study 3011, several randomized studies comparing PCV13 and PCV7 in infants and younger children demonstrated noninferiority of immune responses to the seven serotypes common to both vaccines after a two- or three-dose primary infant series and after the toddler booster dose; immunogenicity and functional immune responses were also demonstrated for the six additional serotypes. The safety and reactogenicity of PCV13 was generally similar to that of PCV7, and PCV13 did not interfere with the immune responses to coadministered routine pediatric vaccines. PCV13 is expected to substantially reduce the incidence of invasive pneumococcal diseases in a manner similar to that which occurred after PCV7 was introduced, and evidence of the protective effectiveness of PCV13 against pneumococcal diseases is emerging.
authors.affiliation: Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand, demail@springer.com.
authors.forename: Greg L
authors.initials: GL
authors.lastname: Plosker
mesh_terms: D000293:Adolescent; D002648:Child; D003362:Cost-Benefit Analysis; D006801:Humans; D007223:Infant; D011008:Pneumococcal Infections / Q000276:immunology / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology*; D013296:Streptococcus pneumoniae / Q000276:immunology; D018074:Vaccines, Conjugate / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology
chemical_list: C538862:13-valent pneumococcal vaccine; D022242:Pneumococcal Vaccines; D018074:Vaccines, Conjugate
references.citation: Vaccine. 2010 Jun 7;28(25):4192-203
references.pmid: 20417262
references.citation: BMC Infect Dis. 2011 Sep 12;11:239
references.pmid: 21910891
references.citation: Clin Infect Dis. 2013 Feb;56(3):e30-9
references.pmid: 23118268
references.citation: Vaccine. 2011 Oct 19;29(45):8042-8
references.pmid: 21871518
references.citation: Vaccine. 2011 Nov 28;29(51):9521-8
references.pmid: 22008820
references.citation: Vaccine. 2012 Mar 9;30(12):2054-9
references.pmid: 22198517
references.citation: Pediatrics. 2010 Jul;126(1):186-90
references.pmid: 20498180
references.citation: Vaccine. 2013 Jun 10;31(26):2839-47
references.pmid: 23588084
references.citation: J Infect. 2012 Jul;65(1):17-24
references.pmid: 22394683
references.citation: BMC Health Serv Res. 2012 Nov 09;12:386
references.pmid: 23137037
references.citation: Int J Infect Dis. 2010 Mar;14(3):e197-209
references.pmid: 19700359
references.citation: Pediatr Infect Dis J. 2011 Dec;30(12):1086-91
references.pmid: 21983216
references.citation: Lancet. 2006 Oct 28;368(9546):1495-502
references.pmid: 17071283
references.citation: Value Health. 2012 Jan-Feb;15(1 Suppl):S15-9
references.pmid: 22265061
references.citation: BMC Infect Dis. 2012 Apr 24;12:101
references.pmid: 22530841
references.citation: Pediatrics. 2010 Mar;125(3):429-36
references.pmid: 20176669
references.citation: Pediatr Infect Dis J. 2013 Mar;32(3):203-7
references.pmid: 23558320
references.citation: Vaccine. 2009 Dec 10;28(1):71-8
references.pmid: 19818722
references.citation: Pediatrics. 2010 Sep;126(3):e493-505
references.pmid: 20732948
references.citation: Pediatr Infect Dis J. 2010 Dec;29(12):e80-90
references.pmid: 21155091
references.citation: Pediatr Blood Cancer. 2015 Aug;62(8):1427-36
references.pmid: 25810327
references.citation: Clin Vaccine Immunol. 2010 Jun;17(6):1017-26
references.pmid: 20427630
references.citation: MMWR Morb Mortal Wkly Rep. 2010 Mar 12;59(9):258-61
references.pmid: 20224542
references.citation: Vaccine. 2011 Sep 2;29(38):6686-94
references.pmid: 21745516
references.citation: Vaccine. 2011 Dec 6;29(52):9640-8
references.pmid: 22027484
references.citation: MMWR Morb Mortal Wkly Rep. 2010 Mar 12;59(9):253-7
references.pmid: 20224541
references.citation: Vaccine. 2012 Nov 26;30(50):7205-13
references.pmid: 23084850
references.citation: Vaccine. 2010 Jun 11;28(26):4249-59
references.pmid: 20416266
references.citation: Pediatr Infect Dis J. 2012 Mar;31(3):297-301
references.pmid: 22330166
references.citation: Paediatr Child Health. 2011 Apr;16(4):233-40
references.pmid: 22468128
references.citation: Pediatr Infect Dis J. 2013 Feb;32(2):e45-53
references.pmid: 23080290
references.citation: Emerg Infect Dis. 2013 Jul;19(7):1074-83
references.pmid: 23763847
references.citation: Vaccine. 2013 May 24;31(22):2572-7
references.pmid: 23583813
references.citation: BMC Infect Dis. 2012 Sep 07;12:207
references.pmid: 22954038
references.citation: Lancet. 2009 Sep 12;374(9693):893-902
references.pmid: 19748398
references.citation: Pediatrics. 2013 Aug;132(2):e324-32
references.pmid: 23821695
references.citation: Vaccine. 2011 Feb 24;29(10):1959-67
references.pmid: 21215830
references.citation: Vaccine. 2011 Sep 22;29(41):7207-11
references.pmid: 21689707
references.citation: Pediatr Infect Dis J. 2012 Jan;31(1):72-7
references.pmid: 21960186
references.citation: Vaccine. 2011 Oct 19;29(45):8077-85
references.pmid: 21864617
references.citation: Vaccine. 2012 Mar 2;30(11):1936-43
references.pmid: 22266291
references.citation: Lancet. 2013 Jan 19;381(9862):214-22
references.pmid: 23158882
references.citation: Clin Microbiol Infect. 2012 Oct;18 Suppl 5:25-36
references.pmid: 22862432
references.citation: Clin Ther. 2012 Jan;34(1):177-89
references.pmid: 22284997
references.citation: Vaccine. 2012 Oct 12;30(46):6600-7
references.pmid: 22939907
references.citation: Paediatr Respir Rev. 2005 Jun;6(2):76-82
references.pmid: 15911451
references.citation: BMC Infect Dis. 2012 Aug 03;12:175
references.pmid: 22863074
references.citation: Curr Opin Pulm Med. 2010 May;16(3):217-25
references.pmid: 20375783
references.citation: Vaccine. 2011 Nov 15;29(49):9127-31
references.pmid: 21983361
references.citation: Pediatr Infect Dis J. 2012 May;31(5):501-8
references.pmid: 22327872
references.citation: J Infect Dis. 2010 Jan 1;201(1):32-41
references.pmid: 19947881
references.citation: Vaccine. 2010 Nov 10;28(48):7634-43
references.pmid: 20883739
references.citation: PLoS One. 2012;7(7):e39927
references.pmid: 22808073
references.citation: Vaccine. 2009 Jun 8;27(28):3681-8
references.pmid: 19442421
references.citation: Vaccine. 2013 Feb 18;31(9):1284-92
references.pmid: 23306363
references.citation: Pediatr Infect Dis J. 2013 Mar;32(3):264-5
references.pmid: 23558322
references.citation: Pediatr Infect Dis J. 2012 Apr;31(4):392-9
references.pmid: 22301472
references.citation: Clin Ther. 2013 Feb;35(2):119-34
references.pmid: 23312274
references.citation: Vaccine. 2010 Nov 10;28(48):7589-605
references.pmid: 20674872
references.citation: Vaccine. 2013 May 24;31(22):2578-83
references.pmid: 23579258
references.citation: Vaccine. 2003 Jul 4;21(23):3265-72
references.pmid: 12804857
references.citation: N Engl J Med. 2003 May 1;348(18):1737-46
references.pmid: 12724479
references.citation: Vaccine. 2012 Dec 14;30(52):7566-72
references.pmid: 23099331
references.citation: Drugs. 2010 Oct 22;70(15):1973-86
references.pmid: 20883054
references.citation: Vaccine. 2013 Jun 7;31(25):2762-71
references.pmid: 23588088
references.citation: Pediatr Infect Dis J. 2013 Mar;32(3):257-63
references.pmid: 23001026
references.citation: Vaccine. 2011 Jul 12;29(31):4963-72
references.pmid: 21621575
references.citation: Lancet. 2006 Mar 4;367(9512):740-8
references.pmid: 16517274
references.citation: Vaccine. 2011 Dec 6;29(52):9675-83
references.pmid: 22008822
references.citation: Vaccine. 2012 Jun 13;30(28):4267-75
references.pmid: 22521287
references.citation: N Engl J Med. 2009 Jan 15;360(3):244-56
references.pmid: 19144940
references.citation: Vaccine. 2010 Jul 26;28(33):5485-90
references.pmid: 20554066
references.citation: Vaccine. 2012 Mar 9;30(12):2206-11
references.pmid: 22273663
references.citation: BMJ. 2010 Jun 02;340:c2509
references.pmid: 20519267
references.citation: Vaccine. 2011 Nov 3;29(47):8564-74
references.pmid: 21945264
references.citation: Pediatr Infect Dis J. 2013 Mar;32(3):266-73
references.pmid: 23011012
references.citation: Pediatr Infect Dis J. 2012 Mar;31(3):249-54
references.pmid: 22173142
references.citation: Pediatrics. 2010 May;125(5):866-75
references.pmid: 20435707
references.citation: J Infect. 2012 Jan;64(1):54-67
references.pmid: 22085813